A Randomized, Double-Blind, Placebo-Controlled Study of Arimoclomol in Patients with Inclusion Body Myositis (S23.010)
Year: 2022
Type: article
Study design: Clinical Trial
Source: Neurology
Authors: Pedro Machado, Richard Barohn, Michael McDermott, Thomas Blaetter, Thomas Lloyd, Aziz Shaibani, Miriam Freimer, Anthony Amato, Emma Ciafaloni, Sarah Jones, Tahseen Mozaffar, Summer Gibson, Matthew Wicklund, Todd Levine, Claus Sundgreen, Thomas Carstensen, Karen Bonefeld, Anders N⊘rkær J⊘rgensen, Karina Phonekeo, Andrew Heim, Laura Herbelin, Michael Hanna, Mazen Dimachkie
Institutions: University College London, University of Missouri, University of Rochester, Orphazyme (Denmark), Johns Hopkins University, The Ohio State University, Brigham and Women's Hospital, University of Rochester Medicine, University of Virginia, University of California, Irvine, University of Utah, HonorHealth, University of Kansas Medical Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389373985